Wei Zhou

Dr. Wei Zhou


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2017 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
LWLi Wang
Li Wang
WZWei Zhou
Wei Zhou
YZYunfeng Zhong
Yunfeng Zhong
YHYongbao Huo
Yongbao Huo
PFPing Fan
Ping Fan
TLTao Liu
Tao Liu
Pancreatic cancer is a highly lethal disease and has the worst prognosis of any major malignancy. G protein-coupled receptor GPR87 is reported to be overexpressed in multiple cancers. The clinical significance and biological role of GPR87 in pancreatic cancer, however, remain to be established. GPR87 expression in pancreatic cancer cell lines, paired patient tissues were determined using western blotting and Real-time PCR. Ninety-six human pancreatic cancer tissue samples were analyzed by immunochemistry (IHC) to investigate the association between GPR87 expression and the clinicopathological characteristics of pancreatic cancer. Functional assays, such as anchorage-independent growth, chicken chorioallantoic membrane (CAM) assay, transwell matrix penetration assay, and Annexin V-FITC and PI staining and a xenograft tumor model were used to determine the oncogenic role of GPR87 in human pancreatic cancer progression. The effect of GPR87 on NF-κB signaling pathway was further investigated using the luciferase reporter assays, and by detection of the NF-κB signaling downstream genes. Herein, we reported that GPR87 was markedly overexpressed in pancreatic cancer cells and clinical tissues. Immunohistochemical analysis showed that the expression of GPR87 significantly correlated with patients’ clinicopathologic features, including clinical stage and tumor-nodule-metastasis (TNM) classification. Pancreatic cancer patients with higher levels of GPR87 expression had shorter overall survival compared to patients with lower GPR87 levels. We gained valuable insights into the mechanism of GPR87 expression in pancreatic cancer cells by demonstrating that overexpressing GPR87 significantly enhanced, whereas silencing endogenous GPR87 inhibited, the proliferation, angiogenesis and increased resistance to gemcitabine-induced apoptosis of pancreatic cancer in vitro and tumorigenicity of pancreatic cancer cells in vivo. Finally, we demonstrated that GPR87 enhanced pancreatic cancer aggressiveness by activating NF-κB signaling pathway. Conclusions: Taken together, these findings suggest that GPR87 plays a critical oncogenic role in pancreatic cancer progression and highlight its potential as a target for pancreatic cancer therapy. Our findings suggest that GPR87 plays a critical oncogenic role in pancreatic cancer progression and highlight its potential as a target for pancreatic cancer therapy.

1 May 2017 in Life Sciences
Verified
Journal Article
Closed access
SHShaobo Hu
Shaobo Hu
QZQichang Zheng
Qichang Zheng
HWHeshui Wu
Heshui Wu
CWChunyou Wang
Chunyou Wang
TLTao Liu
Tao Liu
WZWei Zhou
Wei Zhou

1 January 2020
Verified
Journal Article
Closed access
SHShaobo Hu
Shaobo Hu
QZQichang Zheng
Qichang Zheng
JXJiongxin Xiong
Jiongxin Xiong
HWHeshui Wu
Heshui Wu
WWWeici Wang
Weici Wang
WZWei Zhou
Wei Zhou